Charles Liss

Comparison of Immediate-Release and Controlled Release Carbidopa/Levodopa in Parkinson’s Disease

Gilbert Block, Charles Liss, Scott A. Reines et al. · European Neurology · 1997 · 235 citations

Addition of Alendronate to Ongoing Hormone Replacement Therapy in the Treatment of Osteoporosis: A Randomized, Controlled Clinical Trial¹

Robert Lindsay, Felicia Cosman, Rogerio A. Løbo et al. · The Journal of Clinical Endocrinology & Metabolism · 1999 · 180 citations · Full text

Bone Disease, Biochemical Markers, Bone Health +15

Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure

W.H. Wilson Tang, Randall H. Vagelos, Yin‐Gail Yee et al. · Journal of the American College of Cardiology · 2002 · 97 citations

Heart Failure, Chronic Heart Failure, Cardiovascular Disease +9

Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension

Suzzane Oparil, Eliav Barr, Michelle Elkins et al. · Clinical Therapeutics · 1996 · 83 citations

Non-pharmacological Intervention, Hypertension, Cardiovascular Disease +11

Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults

Daniel M. Musher, Susan B. Manoff, Richard McFetridge et al. · Human Vaccines · 2011 · 79 citations

Immunology, Immunotherapy, Third Doses +17